Valerio Pazienza, Sophie Clément, Paolo Pugnale, Stéphanie Conzelman, Michelangelo Foti, Alessandra Mangia, Francesco Negro – 26 April 2007 – Both molecular and clinical evidence support a link between HCV infection and insulin resistance. We examined the in vitro interaction between the HCV core protein of genotypes 3a and 1b with the insulin‐signaling pathway.

José M. Mato, Shelly C. Lu – 26 April 2007 – S‐Adenosylmethionine (SAMe) has rapidly moved from being a methyl donor to a key metabolite that regulates hepatocyte growth, death, and differentiation. Biosynthesis of SAMe occurs in all mammalian cells as the first step in methionine catabolism in a reaction catalyzed by methionine adenosyltransferase (MAT). Decreased hepatic SAMe biosynthesis is a consequence of all forms of chronic liver injury.

Ralf Weiskirchen, Steffen K. Meurer – 26 April 2007

Natsumi Watanabe, Minoru Tanaka, Kaori Suzuki, Atsushi Kumanogoh, Hitoshi Kikutani, Atsushi Miyajima – 26 April 2007 – Liver development is regulated by various extracellular molecules such as cytokines and cell surface proteins. Although several such regulators have been identified, additional molecules are likely to be involved in liver development. To identify such molecules, we employed the signal sequence trap (SST) method to screen cDNAs encoding a secreted or membrane protein from fetal liver and obtained a number of clones.

Gregory J. Dore, Joanne Micallef – 26 April 2007

Hynek Mergental, Annette S.H. Gouw, Maarten J.H. Slooff, Koert P. de Jong – 24 April 2007

Jacques Belghiti, François Durand – 24 April 2007

Rakesh Sindhi, Kyle Soltys, Geoffrey Bond, Amadeo Marcos, George Mazariegos – 24 April 2007

Cihan Duran, Bulent Aydinli, Yaman Tokat, Yildiray Yuzer, Mecit Kantarci, Metin Akgun, Kamil Yalcin Polat, Bünyami Unal, Refik Killi, S. Selcuk Atamanalp – 24 April 2007 – In living donor liver transplantation (LDLT), obtaining the precise volume of the graft is very important to decrease volume‐related postoperative complications, especially in cases with suspected small‐for size grafts.

Sue V. McDiarmid, Nathan P. Goodrich, Ann M. Harper, Robert M. Merion – 24 April 2007 – Status 1 is the listing category reserved for patients awaiting liver transplantation who are at risk of imminent death. This high allocation priority was intended to benefit patients with acute liver failure and children with severe chronic liver failure. However, the status 1 criteria were not well defined.